XML 37 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Restatement of Previously Issued Financial Statements (Tables) - Restatement [Member]
 3 Months Ended
Mar. 31, 2022
Restatement of Previously Issued Financial Statements (Tables) [Line Items]  
Schedule of balance sheet
   As Reported   Adjustment   As Restated 
Unaudited Balance Sheet As of March 31, 2022            
Accounts payable and accrued expenses  $1,293,769   $222,379   $1,516,148 
Total current liabilities  $2,351,100   $222,379   $2,573,479 
Total liabilities  $13,326,957   $222,379   $13,549,336 
Accumulated deficit  $(3,003,028)  $(222,379)  $(3,225,407)
Total stockholders’ equity  $33,372,539   $(222,379)  $33,150,160 

 
Schedule of statement of operations
   As Reported   Adjustment   As Restated 
Unaudited Statement of Operations During the Three-Month Period Ended March 31, 2022            
Administrative expenses  $462,800   $222,379   $685,179 
Operating expenses  $2,310,235   $222,379   $2,532,614 
Net operating income  $792,988   $(222,379)  $570,609 
Income before income taxes  $736,814   $(222,379)  $514,435 
Net income  $735,666   $(222,379)  $513,287 
Basic net income per share  $0.10   $(0.03)  $0.07 
Diluted net income per share  $0.09   $(0.02)  $0.07 

 
Schedule of statement of stockholders’ equity
   As Reported   Adjustment   As Restated 
Unaudited Statement of Stockholders’ Equity During the Three-Month Period Ended March 31, 2022            
Accumulated Deficit – Net income  $735,666   $(222,379)  $513,287 
Accumulated Deficit – Balance, March 31, 2022  $(3,003,028)  $(222,379)  $(3,225,407)
Total Stockholders’ Equity – Net income  $735,666   $(222,379)  $513,287 
Total Stockholders’ Equity – Balance, March 31, 2022  $33,372,539   $(222,379)  $33,150,160 

 
Schedule of statement of cash flows
   As Reported      Adjustment   As Restated 
Unaudited Statement of Cash Flows During the Three-Month Period Ended March 31,2022            
Net income  $735,666   $(222,379)  $513,287 
Accounts payable and accrued expenses  $(368,382)  $222,379   $(146,003)

 
Schedule of net income per common share
   As Reported   Adjustment   As Restated 
Notes to Unaudited Financial Statements – (n) Net Income Per Common Share During the Three-Month Period Ended March 31, 2022            
Net income attributable to stockholders  $735,666   $(222,379)  $513,287 
Income per share: Basic  $0.10   $(0.03)  $0.07 
Income per share: Diluted  $0.09   $(0.02)  $0.07 

 
Schedule accounts payable and accrued expenses
   As Reported   Adjustment   As Restated 
Notes to Unaudited Financial Statements – 9. Accounts Payable and Accrued Expenses As of March 31, 2022            
Accrued payroll  $322,033   $222,379   $544,412 
Total  $1,293,769   $222,379   $1,516,148 

 
Schedule of segment information
   As Reported   Adjustment   As Restated 
Notes to Unaudited Financial Statements – 17. Segment Information During the Three-Month Period Ended March 31, 2022            
Other – Administrative expenses  $462,800   $222,379   $685,179 
Other – Operating activities  $508,190   $222,379   $730,569 
Other – Net operating loss  $(515,513)  $(222,379)  $(737,892)
Total – Administrative expenses  $462,800   $222,379   $685,179 
Total – Operating activities  $2,310,235   $222,379   $2,532,614 
Total – Net operating income  $792,988   $(222,379)  $570,609 
                

 
Schedule of liquidity and capital resources
   As Reported   Adjustment   As Restated 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources As of March 31, 2022            
Net working capital  $15,948   $(222)  $15,726 
Increase - Amount  $2,218   $(223)  $1,995 
Increase - %   16%   (1)%   15%
Stockholders’ equity  $33,373   $(223)  $33,150 
Increase - Amount  $796   $(223)  $573